Diclofenac sodium in the treatment of primary nocturnal enuresis: double-blind crossover study
- PMID: 3519020
- DOI: 10.1111/j.1440-1681.1986.tb00327.x
Diclofenac sodium in the treatment of primary nocturnal enuresis: double-blind crossover study
Abstract
The prostaglandin synthesis inhibitor diclofenac sodium has been compared with a placebo in the treatment of primary nocturnal enuresis in a double-blind crossover trial. Twenty patients were entered: 14 female, six male; age range 6-17 years. The results showed that diclofenac sodium was significantly more effective than placebo in the treatment of nocturnal enuresis.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
